Subscribe to Search results

The Financial Review Group published proposals for changes to financial support in Scotland.

Published on:

The Department of Health launched consultation on reform of AHOs.

Published on:

The Scottish Government decided to establish a new Scottish scheme.

Published on:

The Department of Health published a response to the consultation and announced the decision to have a single scheme administrator in England.

Published on:

EIBSS became operational.

Published on:

WIBSS became operational.

Published on:

BPS (NI) became operational.

Published on:

Scotland introduced self-declaration regarding impact of Hepatitis C.

Published on:

Announcements of reforms to IBPS (NI).

Published on:

The Government announced changes to the schemes to address disparities.

Published on:

Alpha interferon was licensed for the treatment of Hepatitis C in the UK.

Published on:

Patients reported difficulties accessing alpha interferon treatment.

Published on:

UKHCDO confirmed recombinant Factor 8 as the safest product available for the treatment of people with bleeding disorders.

Published on:

Wales adopted policy of recombinant Factor 8 for all Haemophilia A patients.

Published on:

The Secretary of State for Health announced that recombinant products were to be made available for all children under 16 and previously untreated patients in England.

Published on:

Scotland and Northern Ireland confirmed that all haemophilia patients would be placed on recombinant treatment.

Published on:

Ministers in England accepted recommendation for recombinant to be made available for all adult haemophilia patients on a phased basis over a 4-5 year period starting in 2002-03.

Published on:

Hepatitis C Strategy for England was published.

Published on:

NICE recommended alpha interferon and ribavirin combination therapy for the treatment of moderate to severe Hepatitis C

Published on:

The Haemophilia Society led campaign for full access to recombinant Factor 8.

Published on: